Loading... (0%)
About liver disease

Management Team

The Executive Committee is a non statutory body of GENFIT which ensures the operational management of the Company through the activities and responsibilities of its members. This Committee’s mission is to coordinate between the different scientific, strategic, financial and legal activities of the Company. It is chaired by Jean-François Mouney, Chairman and CEO.

Jean-François Mouney

Chairman of the Board of Directors and Chief Executive Officer of GENFIT, Co-founder

Jean-François Mouney co-founded GENFIT in 1999 after having been actively involved in the incubation of the Company from 1997. Prior to this, he had created, managed and developed several companies specializing in high-performance materials, particularly in the aeronautical industry, since 1979. In 1992, he founded M&M, a consultancy firm specializing in health economics. He was responsible for carrying out a feasibility study for an economic development agency within the field of health and biology in the Nord-Pas-de-Calais region of France and was appointed Chief Executive Officer of this agency since its launch in 1995.

Over a hundred companies have been created as part of this venture, making Eurasanté one of the top European bioincubators and clusters. As Chairman of the Executive Board of GENFIT, he received, in 2003, the Entrepreneur of the Year award, which is organized internationally by Ernst & Young, in the New Technology category. He also received this award in 2004. Jean-François Mouney is also Deputy Chairman of the “Nutrition, Health and Longevity” research hub and is Advisor to the Banque de France since 2008.

Jean-François Mouney is a graduate of the ESCP-Europe Business School, and holds a Master Degree in Economics from the University of Lille.

Dean Hum, Ph. D.

Senior Executive VP and Chief Scientific Officer (CSO)

Dean Hum earned a Ph.D. in Biochemistry from McGill University in Montreal in 1990. An expert in the modulation of transcription factors and nuclear receptors associated with endocrine and cardiometabolic diseases, he held a research position at the University of California in San Francisco before becoming a Professor at Laval University in Quebec.

He joined GENFIT in 2000 as Chief Scientific Officer. Dean Hum is today a key person in the organization of GENFIT. In particular, he is responsible for defining, implementing, employing and coordinating short-, medium- and long-term strategies relating to R&D programs and portfolio.

He coordinates all R&D activities with the CEO and in close collaboration with scientific officers and project managers.

Nathalie Huitorel

Executive VP and Chief Financial and Administrative Officer (CFO)

Nathalie Huitorel is a graduate of the SKEMA Business School (School of Management in Lille, France). For 10 years she was Chief Financial and Administrative Officer for MS COMPOSITES, a company specializing in high-performance composite materials.

She took part in listing a subsidiary of the French company FINUCHEM on the Stock Exchange and has led numerous mergers and acquisitions.

She was appointed Chief Financial and Administrative Officer at GENFIT in October 2007, and oversees the accounting, management and human resources departments.

Sophie Mégnien, M.D.

Chief Medical Officer (CMO)

Sophie Mégnien is an expert in the clinical development of cardiometabolic diseases (hypercholesterolemia, diabetes) and their vascular (atherosclerosis) and hepatic complications. After studying in several countries, including the United States, Sophie Mégnien obtained her degree in Medicine from the University of Paris VI. She completed her internship in the field of clinical trial monitoring.

Since then, she has held a number of posts as Project Manager in the R&D departments of various international pharmaceutical companies such as Smithkline Beecham, Glaxo Wellcome and Bayer. After ten years as a Project Manager, Sophie Mégnien became a consultant in Quality Management and Procedures at Sunnikan Consulting before joining Naturalpha, a company specializing in the coordination of clinical projects in the cardiovascular, metabolic and nutrition fields.

Sophie Mégnien is currently Chief Medical Officer at GENFIT. She is also a member of the Steering Committee of the Liver Forum.

Jean-Christophe Marcoux

Chief Strategy Officer

Jean-Christophe Marcoux is an engineer, and graduated from INSA Lyon in France, having spent part of his time at the University of Leeds in England, and also holds a degree in Strategic Management and Economic Intelligence from EGE in France.

For nearly 15 years, he led international projects and programs in a variety of industrial sectors, in particular in Europe and Asia, and with client and colleagues in the United States. In 2012, he joined IMS Health, now Quintiles IMS, the leading global information and technology services company providing clients in the healthcare industry, where he lead projects in healthcare systems: patient longitudinal studies, forecasting, targeting, profiling, prospective analyses, digital healthcare and innovation.

He joined GENFIT at the end of 2015 to play a cross-disciplinary role regarding tactical, strategic and operational matters and was named Chief Strategy Officer at the end of 2016. He is also Corporate Secretary of The NASH Education ProgramTM, the endowment fund created by GENFIT at the end of 2016.

Laurent Lannoo

Corporate Secretary, Director of Legal Affairs

Laurent Lannoo graduated from the University of Lille law school with a degree in Business Law (DESS Juriste d’Entreprise).

He began his professional career at M&M, a consulting firm, in 1994, becoming partner in 1996. One of the consulting projects led him to join Eurasanté, the public agency for the economic development of healthcare activities in the Nord – Pas de Calais region of France in 1995, where he was in charge of finance and administration (20 employees). Thereafter, he was the Corporate Secretary of the Cœur et Artères foundation and chairman of its executive board from 2005 to 2008.

In 2008, he joined GENFIT as Corporate Secretary and Director of Legal Affairs.